SCIENTIFIC FOCUS INFLAMMATION AND INFECTION
SPEAKER
Univ.-Prof. Dr. Alexander Zarbock
Department of Anaesthesiology, Intensive Care and Pain Therapy
Funded projects
- Vo2/002/25 - Regulation of S100A8 and S100A9 expression in monocytes and neutrophils
Principal investigator: Thomas Vogl
Funding period: 01/2025 - 12/2027 - Lae2/013/24 - The influence of mechnical stimuli on mast cell homeostasis and activation
Principal investigator: Tim Lämmermann
Funding period: 01/2024 - 12/2026 - Om2/014/24 - Restoration of ciliary motility in respiratory cells from individuals with primary ciliary dyskinesia with defined aberrant splicing defects using anti-sense oligonucleotides
Principal investigator: Heymut Omran
Funding period: 01/2024 - 12/2026 - Bru2/015/24 - Role of co-infecting bacteria and bacterial-derived outer membrane vesicles for the pathophysiology of viral pneumonia
Principal investigators: Linda Brunotte, Petra Dersch
Funding period: 01/2024 - 12/2026 - Bör2/023/24 - Deciphering the antibacterial action and targeting mechanisms of Zapnometinib against bacterial pathogens
Principal investigator: Yvonne Börgeling
Funding period: 01/2024 - 12/2026 - Ross2/025/24 - The role of Myo9b in integrin activation and leukocyte recruitment
Principal investigator: Jan Rossaint
Funding period: 01/2024 - 12/2026 - Za2/002/23 - The role of alpha-actinin 1 in integrin activation and leukocyte recruitment
Principal investigator: Alexander Zarbock
Funding period: 01/2023 - 12/2025 - SiRo2/009/23 - Hepatic neutrophil extracellular traps limit dissemination of gut-derived products
Principal investigator: Carlos Silvestre Roig
Funding period: 01/2023 - 12/2025 - Erp2/016/23 - Neutrophil-derived dopamine as a modulator of inflammation
Principal investigator: Luise Erpenbeck
Funding period: 01/2023 - 12/2025
completed IZKF Projects - Scientific Focus Inflammation and Infection
- Wag2/032/23 - Tailoring immune responses during sepsis by DPP4 inhibition
Principal investigator: Nana-Maria Wagner
Funding period: 01/2023 - 12/2025 (Ended 12/2023) - Geo2/004/22 - Functional analysis of human disease mutations in the NPHS1 gene encoding the slit-diaphragm protein Nephrin
Principal investigator: Britta George (since 11/23 Hermann Pavenstädt)
Funding period: 01/2022 - 12/2024 - Ro2/007/22 - Chromatin remodelling during tolerance induction in monocytes
Principal investigator: Johannes Roth
Funding period: 01/2022 - 12/2024 - Dob2/010/22 - Unravelling the factors that shape the intracellular life cycle of uropathogenic E. coli
Principal investigator: Ulrich Dobrindt
Funding period: 01/2022 - 12/2024 - Lue2/013/22 - AntibodyOMICs in autoimmune encephalitis
Principal investigator: Jan Lünemann
Funding period: 01/2022 - 07/2023 - Wie2/014/22 - Role of CD8+ T cells in the pathophysiology of autoimmune encephalitis
Principal investigator: Heinz Wiendl
Funding period: 01/2022 - 12/2024 - Me2/015/22 - Elucidation of factors and mechanisms leading to EHEC O104:H4 hyper-virulence during human infection
Principal investigators: Alexander Mellmann, Petya Berger
Funding period: 01/2022 - 12/2024 - AlG2/026/22 - Novel roles of cellular cholesterol homeostasis in cell dynamics in monocytes
Principal investigator: Noelia Alonso Gonzalez
Funding period: 01/2022 - 12/2024 - Str2/014/21 - The ligand-control of CatSper Ca2+ channels in human sperm
Principal investigator: Timo Strünker
Funding period: 01/2021 - 12/2023 - Bör2/030/21 - Signalling networks in influenza virus assembly and budding - gateway for broad antiviral intervention against enveloped viruses?
Principal investigator: Yvonne Börgeling
Funding period: 01/2021 - 12/2022 - Om2/010/20 - Molecular mechanisms involved in the regulation of the beta-dynein heavy chain in cilia and flagella
Principal investigator: Heymut Omran
Funding period: 01/2020 - 06/2023 - Re2/022/20 - Dynamics of the Late Endosomal Host-Pathogen Interface in IAV Infection
Principal investigator: Ursula Rescher
Funding period: 01/2020 - 06/2023 - De2/006/20 - Analysis of a protective role of coagulation activities and fibrin matrix formation against Yersinia infections
Principal investigator: Petra Dersch
Funding period: 01/2020 - 12/2022 - Fö2/018/20 - The role of hexameric S100A12 complexes and type I interferon signals in promotingIL1/IL18-driven SJIA progression
Principal investigator: Dirk Föll
Funding period: 01/2020 - 12/2022 - Vo2/011/19 - Restriction of autoimmunity in experimental mouse models of arthritis by myeloid-derived suppressor cells (MDSCs)
Principal investigator: Thomas Vogl
Funding period: 01/2019 - 06/2023 - Brau2/013/19 - Impaired function of the nuclear pore complex as a novel pathogenic mechanism in kidney diseases
Principal investigator: Daniela Braun
Funding period: 01/2019 - 06/2022 - Bru2/015/19 - Keeping the balance: Characterization of TRIM28 as a negative regulator of the pulmonary innate immune response during influenza A virus infection
Principal investigator: Linda Brunotte
Funding period: 01/2019 - 06/2022 - Bäu2/009/19 - Creation of a novel antibody-drug conjugate for the treatment of diffuse large B-cell lymphoma
Principal investigator: Sebastian Bäumer
Funding period: 01/2019 - 12/2021 - Ro2/023/19 - Molecular mechanisms of innate immune memory during activation of phagocytes
Principal investigator: Johannes Roth
Funding period: 01/2019 - 10/2021 - Za2/001/18 - Novel functions of pulmonary endothelial and epithelial CXCR2 in leukocyte trafficking to infected lungs and in lung injury
Principal investigator: Alexander Zarbock
Funding period: 01/2018 - 10/2021 - Ross2/010/18 - Renal tubular epithelial TLR4 signaling induces cell cycle arrest and attenuates acute kidney injury
Principal investigator: Jan Rossaint
Funding period: 01/2018 - 10/2021 - Wed2/022/18 - Coordination and control of cell organization through the multifunctional actin regulator INF2
Principal investigator: Roland Wedlich-Söldner
Funding period: 01/2018 - 10/2021 - Fa2/014/18 - InfectionImaging – Development of a pathogen-specific diagnostic imaging marker for infective endocarditis
Principal investigator: Cornelius Faber
Funding period: 01/2018 - 12/2020 - Schw2/020/18 - Mechanisms of mechanosignaling in pancreatic stellate cells and its role for pancreatic cancer
Principal investigator: Albrecht Schwab
Funding period: 01/2018 - 12/2020 - Hei2/027/18 - Mechanisms involved in extracellular (e)DNA-dependent staphylococcal biofilm formation
Principal investigator: Christine Heilmann
Funding period: 01/2018 - 12/2020 - Lud2/008/17 - Influenza Virus-mediated reprogramming of immunologically defective tumor-associated macrophages
Principal investigator: Stephan Ludwig
Funding period: 01/2017 - 10/2020 - Drei2/018/17 - Deciphering bacterial communication under different environmental conditions at high spatio-temporal resolution by novel mass spectrometry imaging technologies
Principal investigators: Klaus Dreisewerd, Jens Soltwisch
Funding period: 01/2017 - 10/2020 - Fau2/014/17 - Bacterial vascular graft infections - impact of sterile inflammation and tissue injury on biofilm formation and bacterially elicited processes
Principal investigators: Andreas Faust, Silke Niemann
Funding period: 1/2017 - 06/2020 - Rüt2/002/16 - ‘CREDIBLE’: A Cre-mediated double reporter system to study cargo transport by delivery systems in vitro and in vivo
Principal investigator: Christian Rüter
Funding period: 01/2016 - 10/2019 - Geo2/003/16 - Neurotrophic receptor kinase 3 (Ntrk3) in podocyte development and disease
Principal investigator: Britta George
Funding period: 01/2016 - 10/2019 - Lo2/004/16 - Role of 4-1BB/4-1BB ligand signalling for the progression of cutaneous inflammation and the development of itch
Principal investigator: Karin Loser
Funding period: 01/2016 - 10/2019 - Om2/015/16 - Molecular characterization of radial spoke composition and defects in Primary Ciliary Dyskinesia
Principal investigator: Heymut Omran
Funding period: 01/2016 - 10/2019 - Kah2/016/16 - The interaction of Staphylococcus aureus with „neutrophil extracellular traps “ (NETs) during the chronic persistent airway infection of cystic fibrosis patients
Principal investigator: Barbara Kahl
Funding period: 01/2016 - 10/2019 - Mat2/019/16 - Mechanobiological investigation of microtubules in tissue development and disease
Principal investigator: Maja Matis
Funding period: 01/2016 - 10/2019 - Dob2/022/16 - Analysis of structural requirements and mechanisms involved in genome plasticity of Escherichia coli
Principal investigator: Ulrich Dobrindt
Funding period: 01/2016 - 10/2019 - Me2/010/16 - EHEC-vesicles: their impact on host-pathogen interaction and gut flora
Principal investigators: Alexander Mellmann, Helge Karch
Funding period: 01/2016 - 12/2018 - Ebl2/014/16 - Redox regulation of integrin-mediated cell-matrix contacts and its role in adhesion, cell morphology, and migration
Principal investigator: Johannes Eble
Funding period: 01/2016 - 12/2018 - Raz2/021/16 - From cell migration to organ formation – Early interactions between somatic cells and migratory germ cells in early gonadogenesis
Principal investigator: Erez Raz
Funding period: 01/2016 - 12/2018 - Ro2/003/15 - The role of calcium -binding proteins MRP8 and MRP14 during cellular dynamics in phagocytes
Principal investigator: Johannes Roth
Funding period: 01/2015 - 10/2018 - EhC2/006/15 - Molecular mechanisms contributing to pathogenesis during influenza virus and Staphylococcus aureus co-infection
Principal investigator: Christina Ehrhardt
Funding period: 01/2015 - 10/2018 - So2/016/15 - The role of Matrix Metalloproteinase (MMP)-2 and MMP-9 in initiating peripheral immune responses: impact on dendritic cell (dc) migration and antigen presentation
Principal investigator: Lydia Sorokin
Funding period: 01/2015 - 10/2018 - Müth2/021/15 - Interaction of Shiga toxin with human intestinal and renal epithelial cells: therapy options for treatment of EHEC-mediated diseases
Principal investigator: Johannes Müthing
Funding period: 01/2015 - 10/2018 - Ros2/007/15 - Role of the three-dimensional chromatin structure in expression control of the tumor suppressor gene PU.1
Principal investigator: Frank Rosenbauer
Funding period: 01/2015 - 12/2017 - Re2/026/15 - Impact of late endosomal cholesterol homeostasis on tetraspanin-based signalling
Principal investigator: Ursula Rescher
Funding period: 01/2015 - 12/2017 - Har2/002/14 - Modified Wnt-signaling and its effects on degenerative and inflammatory joint alterations
Principal investigator: Christine Hartmann
Funding period: 01/2014 - 10/2017 - Vo2/004/14 - The role of alarmins MRP8 and MRP14 in the differentiation of ‚Myeloid-Derived Suppressor Cells ‘ (MDSCs) in allergies and autoimmune diseases
Principal investigator: Thomas Vogl
Funding period: 01/2014 - 10/2017 - Kl2/015/14 - Affinity-dependent modulation of T-cell responses- implications of DHODH and the de novo pyrimidine synthesis pathway
Principal investigator: Luisa Klotz
Funding period: 01/2014 - 10/2017 - Eb2/020/14 - The signalling role of JAM-A during angiogenesis and tumorigenesis
Principal investigator: Klaus Ebnet
Funding period: 01/2014 - 10/2017 - Hei2/027/14 - Characterization of the role of protein glycosylation in the Staphylococcus aureus pathogenesis
Principal investigator: Christine Heilmann
Funding period: 01/2014 - 10/2017 - Za2/001/14 - The role of SKAP-HOM in integrin activation, leukocyte recruitment, and inflammation
Principal investigator: Alexander Zarbock
Funding period: 01/2014 - 12/2016 - Ge2/009/14 - Plasma membrane wound repair in mechanically stressed cells
Principal investigator: Volker Gerke
Funding period: 1/2014 - 12/2016 - Lud2/017/13 - Unraveling the phosphoproteom of influenza virus infected cells
Principal investigator: Stephan Ludwig
Funding period: 01/2013 - 10/2016 - Cia2/013/13 - Membrane transporters as mediators of cisplatin effects and side effects
Principal investigators: Giuliano Ciarimboli, Eberhard Schlatter, Antoinette am Zehnhoff-Dinnesen
Funding period: 01/2013 - 09/2016 - Schl2/001/13 - Germline stem cells and their niches: Is male infertility associated with defects of migration and colonization of spermatogonia?
Principal investigator: Stefan Schlatt
Funding period: 01/2013 -12/2015 - SchMA2/014/13 - Application of bacterial immune regulatory cell -penetrating proteins in murine models of inflammatory bowel disease
Principal investigator: M. Alexander Schmidt
Funding period: 01/2013 -12/2015 - Om2/009/12 - The role of cytoplasmic pre-assembly of axonemal components in primary ciliary dyskinesia
Principal investigator: Heymut Omran
Funding period: 01/2012 - 10/2015 - Dob2/013/12 - Regulation of the biosynthesis of the enterobacterial genotoxin colibactin
Principal investigator: Ulrich Dobrindt
Funding period: 01/2012 - 10/2015 - Pap2/015/12 - SUMO-1 as a modulator of inflammatory bone loss: Molecular mechanisms and therapeutic implications
Principal investigator: Thomas Pap
Funding period: 01/2012 - 10/2015 - Me2/021/12 - Microevolution of enterohemorrhagic Escherichia coli (EHEC) O104:H4 and its impact on the pathogen-host interaction
Principal investigators: Alexander Mellmann, Helge Karch
Funding period: 01/2012 - 10/2015 - Mei2/017/12 - Functions of CDKs in proliferation and inflammation
Principal investigator: Michael Meisterernst
Funding period:1/2012 - 12/2014 - Lo2/004/11 - Relevance of OX40-OX40 ligand signalling for allergic and anti-microbial cutaneous immune responses
Principal investigators: Karin Loser, Stefan Beissert
Funding period: 01/2011-10/2014 - Mül2/020/11 - The relevance of Histone 4 acetyltransferases in myeloid differentiation
Principal investigator: Carsten Müller-Tidow
Funding period: 01/2011 - 10/2014 - Lud2/010/11 - Activation and function of the p38 MAP kinase pathway in influenza virus infected cells
Principal investigator: Stephan Ludwig
Funding period: 01/2011 - 12/2013 - Eh2/019/11 - New anti-inflammatory mechanisms of glucocorticoids in vivo
Principal investigators: Jan Ehrchen, Cord Sunderkötter
Funding period:1/2011 - 12/2013 - Be2/023/11 - Pathogenicity of Staphylococcus lugdunensis
Principal investigator: Karsten Becker
Funding period: 01/2011 - 12/2013 - Ro2/004/10 - Characterisation of the molecular mechanisms of LPS- or stress-induced microbial tolerance in phagocytes
Principal investigator: Johannes Roth
Funding period:1/2010-10/2013 - Ge2/016/10 - Ca2+-dependent regulation of membrane/cytoskeleton interactions in migratory leukocytes and tumour cells
Principal investigator: Volker Gerke
Funding period: 01/2010 -10/2013 - Re2/017/10 - Annexin A8 and the pathophysiology of tumours
Principal investigator: Ursula Rescher
Funding period: 01/2010 -10/2013 - Müth2/028/10 - Interaction of glycosphingolipids from human cells with virulence factors of entero-hemorrhagic Escherichia coli (EHEC)
Principal investigator: Johannes Müthing
Funding period: 01/2010 -10/2013 - Löf2/030/10 - Mechanisms of intracellular persistence of Staphylococcus aureus via formation of highly dynamic phenotypes
Principal investigators: Bettina Löffler, Georg Peters
Funding period: 01/2010 -10/2013 - Za2/001/10 - The role of phopholipase C gamma (PLCγ) isoforms in selectin-mediated leukocyte activation
Principal investigator: Alexander Zarbock
Funding period: 01/2010-12/2012 - Wix2/005/10 - The LIM-domain protein FHL2 as a novel regulator of innate cellular anti-viral response
Principal investigators: Viktor Wixler, Christina Ehrhardt
Funding period: 01/2010-12/2012 - Goe2/023/10 - Role of platelet adhesion receptors for the acute and chronic inflammation of the skin
Principal investigator: Tobias Görge
Funding period: 01/2010-12/2012 - Vo2/014/09 - Novel strategies in sepsis therapy – characterization of pro-inflammatory mechanisms of human MRP8 and MRP14
Principal investigator: Thomas Vogl
Funding period: 01/2009 - 10/2012 - Hei2/022/09 - Molecular characterization of the SasC -mediated mechanism of cell aggregation and biofilm formation in Staphylococcus aureus
Principal investigator: Christine Heilmann
Funding period: 01/2009 - 10/2012 - Kah2/024/09 - In vivo evolution of Staphylococcus aureus during chronic airway infection of cystic fibrosis patients
Principal investigator: Barbara Kahl
Funding period: 01/2009 - 10/2012 - Schä2/020/09 - Molecular imaging of activated matrix metalloproteinases in encephalomyelitis
Principal investigators: Michael Schäfers, Klaus Kopka, Lydia Sorokin
Funding period: 01/2009 - 12/2011 - Eb2/028/09 - Regulation of membrane polarity in endothelial cells by the VE-cadherin - Par protein complex
Principal investigator: Klaus Ebnet
Funding period: 01/2009 - 12/2011 - Me2/023/08 - Mobility and dynamic of pathogenicity determinants of enterohaemorrhagic Escherichia coli (EHEC) during infection
Principal investigators: Alexander Mellmann, Helge Karch
Funding period: 01/2008 - 10/2011 - SchMA2/027/08 - Probiotic Bacteria and the Gastrointestinal Barrier: target Structures and Molecular Repair Mechanisms
Principal investigator: M. Alexander Schmidt
Funding period: 01/2008 - 10/2011 - Schw2/030/08 - Calcium channels as mechanosensors in migrating cells
Principal investigator: Albrecht Schwab
Funding period: 01/2008 - 10/2011 - Mül2/018/07 - Combinatorial gene regulation as a prerequisite for cellular dynamics in hematopoietic differentiation
Principal investigator: Carsten Müller-Tidow
Funding period: 01/2007 -10/2010 - Sun2/017/07 - Influence of initial epidermal cytokine expression on the adaptive immune response in experimental Leishmaniasis
Principal investigators: Cord Sunderkötter, Jan Ehrchen
Funding period: 01/2007 -10/2010 - Pap2/003/07 - Regulation of apoptosis in rheumatoid arthritis syvnovial fibroblasts by the tissue inhibitor of metalloproteinases (TIMP-3)
Principal investigator: Thomas Pap
Funding period: 1/2007 - 12/2009 - Lo2/017/07 - Relevance of cutaneous RANK-RANKL signalling in immunity
Principal investigator: Karin Loser
Funding period: 01/2007 - 12/2009 - Wi2/023/07 - Potential of spermatogonial stem cells for cellular renewal in testis and bone marrow
Principal investigators: Joachim Wistuba, Steffen Koschmieder, Jörg Gromoll
Funding period: 01/2007 - 12/2009 - Re2/039/07 - Annexin 2 and raft domains and their associated proteins in cellular motility
Principal investigator: Ursula Rescher
Funding period: 01/2007 - 12/2009 - Fö2/005/06 - Molecular characterisation of RAGE-mediated endothelial activation
Principal investigators: Dirk Föll, Dorothee Viemann
Funding period: 01/2006 - 10/2009 - Ro2/012/06 - Anti-inflammatory mechanisms of macrophages
Principal investigator: Johannes Roth
Funding period: 01/2006 - 10/2009 - Ge2/017/06 - Regulation of the acute secretion of inflammatory and thrombogenic factors from vascular endothelial cells
Principal investigator: Volker Gerke
Funding period:1/2006 - 10/2009 - Lud2/032/06 - Molecular basis of the oncolytic activity of RNA viruses
Principal investigator: Stephan Ludwig
Funding period: 01/2006 - 10/2009 - Si2/039/06 - Mechanisms of induction of apoptosis by Staphylococcus aureus in leukocytes and endothelial cells
Principal investigators: Bhanu Sinha, Bettina Löffler
Funding period: 01/2006 - 10/2009 - Kuc2/018/06 - The deletion of CCR6 inhibits Peyer’s patches and isolated lymphoid follicles – implications of the organized GALT for the intestinal immune system
Principal investigators: Torsten Kucharzik, Andreas Lügering
Funding period: 01/2006 - 12/2008 - Schae2/026/06 - Macrophage-colony stimulating factor isoforms: relevance and regulation in Lupus nephritis
Principal investigators: Liliana Schaefer, Roland M. Schaefer, Peter Bruckner
Funding period: 01/2006 - 12/2008 - Stei2/017/06 Molecular and functional investigations on the role of endopeptidases for the regulation of neuropeptide receptor signalling
Principal investigators: Martin Steinhoff, Thomas Luger
Funding period: 01/2006 - 12/2008 - Ser2/038/06 - JAK-STAT signal transduction in leukemic transformation – role of SOCS1 as a conditional oncogene
Principal investigators: Hubert Serve, Christian Brandts
Funding period: 01/2006 - 12/2008 - Vest2/006/04 - Role of CD99 in transendothelial migration and extravasation of leukocytes
Principal investigator: Dietmar Vestweber
Funding period: 06/2004 - 12/2006 - Na2/009/04 - Analyis of the S100 protein associated proteome in inflammation
Principal investigator: Wolfgang Nacken
Funding period: 06/2004 - 12/2006 - Kess2/023/04 - Hematopoetic stem cells as targets for antivascular treatment strategies in cancer
Principal investigators: Torsten Kessler, Rolf Mesters
Funding period: 06/2004 - 12/2006 - Hei2/042/04 - Molecular characterisation of adhesive interactions between Staphylococcus aureus and candida
Principal investigators: Christine Heilmann, Chrsitof von Eiff, Karsten Becker
Funding period: 06/2004 - 12/2006 - Ka2/061/04 - Pathomechanisms of the interaction between enterohaemorrhagic Escherichia coli and intestinal epithelial cells
Principal investigators: Helge Karch, Alexander W. Friedrich
Funding period: 06/2004 - 12/2006 - Lo2/065/04 - Investigations on the role of interleukin (IL)-15 for linking adaptive and innate cutaneous immunity
Principal investigator: Karin Loser
Funding period: 06/2004 - 12/2006 - Mül2/096/04 - The role of the Cyclin A1 interacting protein (FOCA1 – Friend of Cyclin A1) for cell cycle progression and proliferation of haematopoietic cells
Principal investigator: Carsten Müller-Tidow
Funding period: 06/2004 - 12/2006 - Pa2/108/04 - The role of C/EBP-homologous protein (CHOP) in oxygen-radical mediated damage of podocytes
Principal investigator: Hermann-Joseph Pavenstädt
Funding period:0 6/2004 - 12/2006 - Ra2/109/04 - New therapeutic strategies for implant associated infections in surgery of the musculoskeletal system
Principal investigator: Michael Raschke
Funding period:0 6/2004 - 12/2006 - Fö2/026/04 - Functional characterisation of calium-binding protein S100A12 specifically expressed in granulocytes
Principal investigators: Dirk Föll, Johannes Roth
Funding period:0 6/2004 - 12/2005 - Re2/033/04 - Functional characterisation of calium-binding protein S100A12 specifically expressed in granulocytes
Principal investigators: Ursula Rescher, Volker Gerke
Funding period: 06/2004 - 12/2005 - Si2/048/04 - Analysis of structure and function of Staphylococcus aureus-FnBPin invasion of human host cells
Principal investigators: Bhanu Sinha, Christine Heilmann, Georg Peters
Funding period: 06/2004 - 12/2005 - Schae2/004/04 - Pathogenic role of proteolycans in the development of glomerulosclerosis and obstructive neuropathy
Principal investigators: Roland M. Schaefer, Liliana Schaefer, Frank G. Echtermeyer
Funding period: 06/2004 - 12/2005 - Ser2/041/04 - Functional relevance of Flt-3 target genes in haematopoesis
Principal investigators: Hubert Serve, Christian Barndts
Funding period: 06/2004 - 12/2005 - Stei2/103/04 - Molecular mechanisms of cutaneous neurogenic inflammation
Principal investigators: Martin Steinhoff, Thomas Luger
Funding period:0 6/2004 - 12/2005 - Schl2/008/04 - Pathophysiology and cellular mechanisms of tubular transport differences after kidney transplantation
Principal investigators: Eberhard Schlatter, Gerd Gabriels
Funding period: 06/2004 - 12/2004 - Kul2/016/04 - Molecular mechanisms of UV-induced apoptosis
Principal investigators: Dagmar Kulms, Thomas Schwarz
Funding period: 06/2004 - 12/2004
- Wag2/032/23 - Tailoring immune responses during sepsis by DPP4 inhibition